128 related articles for article (PubMed ID: 7302319)
1. [Experimental electropharmacologic studies of cerebral ischemia (author's transl)].
Depoortere H
Rev Electroencephalogr Neurophysiol Clin; 1981; 10(3):207-14. PubMed ID: 7302319
[TBL] [Abstract][Full Text] [Related]
2. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
[TBL] [Abstract][Full Text] [Related]
3. Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia.
Barzaghi F; Dragonetti M; Formento ML; Boissier JR
Arzneimittelforschung; 1985; 35(2):472-7. PubMed ID: 4039569
[TBL] [Abstract][Full Text] [Related]
4. Cerebral vasodilators (second of two parts).
Cook P; James I
N Engl J Med; 1981 Dec; 305(26):1560-4. PubMed ID: 7031468
[No Abstract] [Full Text] [Related]
5. Cerebral metabolic, hemodynamic and antihypoxic properties of l-eburnamonine.
Linée P; Lacroix P; Le Polles JB; Aurousseau M; Boulu R; Van den Driessche J; Albert O
Eur Neurol; 1978; 17 Suppl 1():113-20. PubMed ID: 753626
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
Schenker H
Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
[No Abstract] [Full Text] [Related]
7. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
Ambrozi L; Bruck J; Tschabitscher H
Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
[No Abstract] [Full Text] [Related]
8. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
Mikus P
Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
[TBL] [Abstract][Full Text] [Related]
9. Cerebral regulation-cerebral regulators.
Braun P
Ther Hung; 1980; 28(3):98-104. PubMed ID: 7221974
[No Abstract] [Full Text] [Related]
10. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
Witzmann HK; Blechacz W
Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
[No Abstract] [Full Text] [Related]
11. [Vincamine in the therapy of cerebral vascular diseases in the aged].
De Candia O; Bartolucci E; Mancinella A; Baghiris D
Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
Desruelles J; Camart JF
LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
[No Abstract] [Full Text] [Related]
13. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
Periti P; Periti G; Colombo Pirola L
Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
[No Abstract] [Full Text] [Related]
14. [Controlled testing of vincamine with special reference to the flow properties of blood].
Klein M; Szobor A; Bräuer H
Med Klin; 1979 Oct; Suppl():29-36. PubMed ID: 542163
[No Abstract] [Full Text] [Related]
15. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
Mazzola C; Della Torre F; Izzo M; Colombo Pirola L
Clin Ter; 1979 Dec; 91(5):485-503. PubMed ID: 397034
[No Abstract] [Full Text] [Related]
16. [Efficacy of Cetal retard in cerebral insufficiency in general practice].
Bartels H
Med Klin; 1979 Oct; Suppl():46-7. PubMed ID: 542167
[No Abstract] [Full Text] [Related]
17. [The effect of vincamine on vigilance disorders in the elderly (author's transl)].
Moreau J
Sem Hop; 1978 Nov 8-15; 54(37-40):1181-4. PubMed ID: 217102
[TBL] [Abstract][Full Text] [Related]
18. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
Holemans P
Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
[No Abstract] [Full Text] [Related]
19. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
Maeda T
Nihon Rinsho; 1985 Feb; 43(2):389-91. PubMed ID: 3889412
[No Abstract] [Full Text] [Related]
20. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
Roth E; Elbaum D; Godoy E; Nagel RL
Nouv Rev Fr Hematol (1978); 1979 Jan; 20(4):611-9. PubMed ID: 440964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
